Literature DB >> 1662856

Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component.

T Höll1, P Kleihues, M G Yasargil, O D Wiestler.   

Abstract

This report describes an unusual medullomyoblastoma which developed in the cerebellar vermis of a 6-year-old girl. Histological investigation showed a highly cellular and predominantly undifferentiated tumor. Myogenic differentiation was prominent in clusters of large tumor cells with eosinophilic cytoplasm and immunoreactivity for desmin and myoglobin. Electron microscopy revealed the presence of immature Z-bands. Immunohistochemically, numerous cells showed incipient expression of myoblastic marker antigens, supporting the view that medulloblastomas and related primitive neuroectodermal tumors possess the potential for non-neural differentiation. In addition, there was evidence of advanced neuronal differentiation, with expression of neuron-specific enolase, synaptophysin, retinal S-antigen, and the formation of ganglioid tumor cells. Occassional neoplastic cells expressed glial fibrillary acidic protein without morphologically detectable astrocytic differentiation. Associated with the neoplasm was brain tissue containing clusters of neuronal cells and focal accumulations of immature oligodendroglia-like cells which expressed neuronal marker antigens. This unusual component resembled a hamartomatous lesion and would support the hypothesis that the cerebellar medullomyoblastoma originated from a teratomatous or malformative lesion. Alternatively, this component may constitute the end stage of advanced neuronal differentiation of a primitive neuroectodermal tumor.

Entities:  

Mesh:

Year:  1991        PMID: 1662856     DOI: 10.1007/bf00296553

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  [The question of medullomyoblastoma].

Authors:  S Patt; F Oppel; J Cervós-Navarro
Journal:  Zentralbl Allg Pathol       Date:  1989

2.  Medullomyoblastoma: a case report.

Authors:  C R Lai; D M Ho; H C Liu
Journal:  Zhonghua Yi Xue Za Zhi (Taipei)       Date:  1989-07

3.  Central neuroblastic tumour associated with smooth muscle fibers. A study in the optic and electron microscopes.

Authors:  O Vuia; H Hager
Journal:  Eur Neurol       Date:  1975       Impact factor: 1.710

4.  Ganglioglial differentiation in medulloblastoma.

Authors:  M Kudo; M Shimizu; Y Akutsu; H Imaya; M N Chen; M Miura
Journal:  Acta Pathol Jpn       Date:  1990-01

5.  Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.

Authors:  V E Gould; D S Jansson; W M Molenaar; L B Rorke; J Q Trojanowski; V M Lee; R J Packer; W W Franke
Journal:  Lab Invest       Date:  1990-04       Impact factor: 5.662

6.  Fine structure of myomedulloblastoma.

Authors:  R Stahlberger; R L Friede
Journal:  Acta Neuropathol       Date:  1977-01-31       Impact factor: 17.088

7.  Cerebellar neoplasm of mixed mesenchymal and neuroepithelial origin. Case report.

Authors:  S Shuangshoti; S O'Charoen
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

8.  Striated muscle cells in the leptomeninges in cerebral dysplasia.

Authors:  M W Ambler
Journal:  Acta Neuropathol       Date:  1977-11-28       Impact factor: 17.088

9.  Melanotic rhabdomyomedulloblastoma or teratoid tumour of the cerebellar vermis.

Authors:  S J Duinkerke; J L Slooff; F J Gabreëls; W O Renier; H O Thijssen; J H Biesta
Journal:  Clin Neurol Neurosurg       Date:  1981       Impact factor: 1.876

10.  Medulloblastoma with glial and rhabdomyoblastic differentiation. A myoglobin and glial fibrillary acidic protein immunohistochemical and ultrastructural study.

Authors:  D W Dickson; M N Hart; A Menezes; P A Cancilla
Journal:  J Neuropathol Exp Neurol       Date:  1983-11       Impact factor: 3.685

View more
  3 in total

1.  Tumor cell complementation groups based on myogenic potential: evidence for inactivation of loci required for basic helix-loop-helix protein activity.

Authors:  A N Gerber; S J Tapscott
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

2.  Medullomyoblastoma: report of two cases.

Authors:  D Schiffer; M T Giordana; S Pezzotta; T Pezzulo; M C Vigliani
Journal:  Childs Nerv Syst       Date:  1992-08       Impact factor: 1.475

Review 3.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.